Home » Consulting Services » Retail Pharmacy Decision Support »

Retail Pharmacy Decision Support

PHSL will develop strategic responses to marketplace dynamics to enable your organization to capitalize on the industry changes to drive sales and profits. PHSL continually researches industry best practices leading to improved financial results while avoiding costly mistakes. Our strategy is to fully understand your business challenge prior to developing an approach to provide decision support services.

View our case studies relating to retail pharmacy decision support:

Generic Discount Programs – Monitoring and Measuring Uptake and Retention

Integrated Delivery System Retail Pharmacy Assessment

Pharmacy Validates Business and Information Technology Practices

Retail Pharmacy Profitability on 90 Days’ Supply Prescriptions

May 2023 Question of the Month

Which type of project(s) could you or your organization most benefit from in 2023?

Future forecast: 0%

Competitor comparison: 20%

Contract variance analysis: 20%

Historical trend analysis: 20%

Legislative/regulatory impact: 0%

Procurement cost/savings: 20%

Stakeholder program impact: 20%

April 2023 Question of the Month

In July 2022, the FDA proposed expanding the NDC to a uniform 12 numeric digit format to accommodate future needs when all options using the current formats have been exhausted. Alternative options shared by the industry have asked the FDA to consider retaining the current NDC formats and allow the use of alpha characters when all numeric options have been exhausted.

Which of the following transition types is your organization prepared for in the next 5 years?

Make the transition to alphanumeric using the current NDC formats: 70%

Make the transition to the 12-digit numeric format: 20%

Make the transition to neither option: 10%

Make the transition to either option: 0%

March 2023 Question of the Month

What information would you most like to gain from an Online Listening Assessment for a particular drug therapy or device? (Multiple selections allowed)

Prescribing & Dispensing Concerns: 25%

Competitor Comparisons: 25%

Prescribing Information Alignment: 17%

Coverage & Reimbursement: 17%

Patient Affordability: 8%

Misinformation: 8%

Disease State Concerns: 0%